Q: Can you please provide your opinion of AbbVie? It has done well since being spun off from Abbott Labs and pays a nice dividend. However, it is not followed by any of the research services that I subscribe to so I am not entirely comfortable holding it. With CML out of the picture, my only other healthcare holding is JNJ. Should I consider replacing ABBV with VRX or perhaps PLB? Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.